What AI says about FYR Diagnostics

FYR Diagnostics leverages AI-powered multi-omic insights from extracellular vesicles in blood to decode RNA and protein signals beyond DNA, aiming to improve biomarkers, trial design, and patient outcomes. Its EV-Omics (EVO) platform uses SPARCs-enriched EVs to provide a detailed molecular snapshot of disease, enabling dynamic monitoring from screening through therapy selection. They partner with drug developers, diagnostics companies, and researchers, offering tailored study design and data outputs across discovery to clinical validation in precision medicine.